CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsushima, H.
Right arrow Articles by Tomonaga, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsushima, H.
Right arrow Articles by Tomonaga, M.

Cell Growth & Differentiation, Vol 8, Issue 12 1317-1328, Copyright © 1997 by American Association of Cancer Research


ARTICLES

Human erythropoietin receptor increases GATA-2 and Bcl-xL by a protein kinase C-dependent pathway in human erythropoietin-dependent cell line AS-E2

H Tsushima, Y Urata, Y Miyazaki, K Fuchigami, K Kuriyama, T Kondo and M Tomonaga
Department of Hematology, Nagasaki University School of Medicine, Japan.

Erythropoietin (Epo) is a cytokine known to stimulate proliferation and differentiation of erythroid cells. However, recent gene disruption experiments demonstrated that Epo receptor signaling is not an obligatory step in erythroid differentiation. Here, we describe the role of Epo in proliferation, terminal differentiation, and apoptosis in a novel human Epo-dependent cell line, AS-E2. Upon withdrawal of Epo, the cells ceased to proliferate and underwent apoptotic death. Accompanying this cell death, an increase in the number of hemoglobin-positive cells of approximately 2-fold was observed. This was associated with immediate up-regulation of the GATA-1:GATA-2 ratio and down-regulation of Bcl-xL. Treatment with Epo or 12-O-tetradecanoyl-phorbol-13-acetate (TPA) up-regulated expression of GATA-2 and Bcl-xL, and these elevations were inhibited by inhibitors of protein kinase C (PKC), H7 and H8. HA1004, a structural analogue of H7 but a poor inhibitor of PKC, had no inhibitory effect. Therefore, in AS-E2 cells, it is likely that Epo plays a role in (a) proliferation, (b) inhibition of differentiation, and (c) survival, by maintaining GATA-2 and Bcl-xL expression through activation of PKC.


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Hossain, S. M. Qadri, N. Xu, Y. Su, F. S. Cayabyab, B. Heit, and L. Liu
Endothelial LSP1 Modulates Extravascular Neutrophil Chemotaxis by Regulating Nonhematopoietic Vascular PECAM-1 Expression
J. Immunol., September 1, 2015; 195(5): 2408 - 2416.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Hafid-Medheb, Y. Augery-Bourget, M.-N. Minatchy, N. Hanania, and J. Robert-Lezenes
Bcl-XL is required for heme synthesis during the chemical induction of erythroid differentiation of murine erythroleukemia cells independently of its antiapoptotic function
Blood, April 1, 2003; 101(7): 2575 - 2583.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
D. R. Mercatante, J. L. Mohler, and R. Kole
Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents
J. Biol. Chem., December 20, 2002; 277(51): 49374 - 49382.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. von Lindern, M. P.-v. Amelsvoort, T. van Dijk, E. Deiner, E. van den Akker, S. van Emst-de Vries, P. Willems, H. Beug, and B. Lowenberg
Protein Kinase C {alpha} Controls Erythropoietin Receptor Signaling
J. Biol. Chem., November 3, 2000; 275(44): 34719 - 34727.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Imanishi, K. Yamamoto, H. Tsushima, Y. Miyazaki, K. Kuriyama, M. Tomonaga, and T. Matsuyama
Identification of a Novel Cytokine Response Element in the Human IFN Regulatory Factor-1 Gene Promoter
J. Immunol., October 1, 2000; 165(7): 3907 - 3916.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Haslauer, K. Baltensperger, and H. Porzig
Erythropoietin- and Stem Cell Factor-Induced DNA Synthesis in Normal Human Erythroid Progenitor Cells Requires Activation of Protein Kinase Calpha and Is Strongly Inhibited by Thrombin
Blood, July 1, 1999; 94(1): 114 - 126.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. von Lindern, M. P.-v. Amelsvoort, T. van Dijk, E. Deiner, E. van den Akker, S. van Emst-de Vries, P. Willems, H. Beug, and B. Lowenberg
Protein Kinase C {alpha} Controls Erythropoietin Receptor Signaling
J. Biol. Chem., November 3, 2000; 275(44): 34719 - 34727.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1997 by the American Association of Cancer Research.